While stable expression of an active FOXO3a mutant induced a similar level of quiescence to TKIs alone, shRNA-mediated knockdown of FOXO3a drove CML cells into cell cycle and potentiated TKI-induced apoptosis. The gene discussed is FOXO3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.